Skip to main content

Peer Review reports

From: A pharmacovigilance study of olanzapine/samidorphan based on FDA Adverse Event Reporting System (FAERS)

Original Submission
18 Dec 2024 Submitted Original manuscript
4 Feb 2025 Reviewed Reviewer Report - Daria Schetz
7 Feb 2025 Reviewed Reviewer Report
10 Feb 2025 Author responded Author comments - Huafang Li
Resubmission - Version 2
10 Feb 2025 Submitted Manuscript version 2
Publishing
13 Feb 2025 Editorially accepted
20 Feb 2025 Article published 10.1186/s40360-025-00869-4

You can find further information about peer review here.

Back to article page